Logo
  • About
  • Contact
  • (888) 441-8033

UGI Upgrades Scheduled to Begin in Clarion Could Provide Opportunities to Convert to Natural Gas

FOR IMMEDIATE RELEASE Release Date: March 24, 2025 UGI Utilities, Inc. is scheduled to begin system upgrades in Clarion on Monday, March 31. The gas main replacement project is part of UGI’s commitment to provide safe and reliable service. The replacement is also an opportunit...

View full release

Stonegate Capital Partners Initiates Coverage on Surf Air Mobility Inc. (NYSE: SRFM)

DALLAS, TX -- March 24th, 2025 -- Surf Air Mobility Inc. (NYSE: SRFM): Stonegate Capital Partners initiates their coverage on Surf Air Mobility Inc. (NYSE: SRFM). SRFM reported revenue, adj EBITDA, and adj EPS of $28.0M, ($6.9)M, and $1.27, respectively. For the full year the ...

View full release

Stonegate Capital Partners Initiates Coverage on GoHealth Inc. (NASDAQ: GOCO)

DALLAS, TX -- March 24th, 2025 -- GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners initiates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a strong fourth quarter in 2024, highlighted by substantial revenue growth and operational efficiencies...

View full release

Stonegate Capital Partners Updates Coverage on Aquafil Group (ECNL.MI) Q4 2024

DALLAS, TX -- March 19th, 2025 -- Aquafil Group (ECNL.MI): Stonegate Capital Partners updates coverage on Aquafil Group (ECNL.MI). In 4Q24, ECNL observed continued improvement within the macro environment in both EMEA and Asia markets, with volumes growing year over year and a...

View full release

Expanse (GMGI) Strengthens European Presence with Slotino Integration

Las Vegas, 17 March 2025 - Expanse Studios, a subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), continues its international expansion with a new partnership with Slotino, one of Bulgaria’s leading online casino operators. Facilitated by Dench eGaming Solutions, this integ...

View full release

Pacylex Pharmaceuticals Announces the first Acute Myeloid Leukemia (AML) patient dosed with zelenirstat in a new Phase 1/2 clinical trial

Edmonton, Alberta, Canada March 17, 2025. Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company and world leader in developing N-myristoyltransferase inhibitors (NMTis) for cancer. Oral zelenirstat is under clinical investigation as a first-in-class...

View full release

BioUtah Applauds Pitch Competition Winners at the 2025 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit

Salt Lake City, Utah - March, 14, 2025 - BioUtah today applauds the four winning life sciences companies of its Pitch Competition held March 13 during the 2025 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of ...

View full release

Wendt Partners Establishes New HubSpot Practices in AI and Global Growth

New York, NY (March 5, 2025) - Wendt Partners, an award-winning HubSpot Elite Solutions Partner headquartered in New York City, announced today that the firm is establishing two new practice groups within the firm. Both will be delivered as part of the firm’s Growth Solutions ...

View full release

UGI Project Beginning in Catasauqua Could Fuel Natural Gas Conversions

FOR IMMEDIATE RELEASE Release Date: March 13, 2025 UGI Utilities, Inc. is scheduled to begin system upgrades in Catasauqua on Monday, March 17. The gas main replacement project is part of UGI’s commitment to provide safe and reliable service. The replacement is also an opport...

View full release

BOSTON REALTY ADVISORS REPRESENTS 399 WASHINGTON ST. OWNER IN SALE

BOSTON – Boston Realty Advisors, the Boston area’s largest independent commercial real estate brokerage, represented the owners of 399 Washington Street in the sale the prominent Downtown retail and office property that had long been vacant. A bank lender, which had taken the ...

View full release
  • « First
  • ‹ Prev
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • Next ›
  • Last »
©2025 Reportable, Inc.
Terms and Conditions | Privacy Policy